Author

Rosario Hernández‐Armengol

Cedars-Sinai Medical CenterORCID 0000-0002-9922-4009Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Said Álamos-MusreiD· 1 shared Carolina OteroiD· 1 shared Che‐Yu ChangiD· 1 shared Christian StehlikiD· 1 shared Daniel Paredes‐SabjaiD· 1 shared David R. GibbiD· 1 shared Diego Cea· 1 shared F.B. GiliD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Said Álamos-MusreORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Repurposing nystatin and taurocholate to target intracellular spore persistence during antibiotic treatment to prevent recurrent Clostridioides difficile infection.

Pablo Castro-Córdova, Maria Mendoza-Leon, A. Said Álamos-Musre, Nicolás Montes-Bravo, Juan Muñoz-Miralles, Fernando Díaz-Yáñez, Felipe M. Llancalahuén, Diego Cea, Rosario Hernández‐Armengol, Javiera Valeria Gallegos, Katherine Mondaca, Carolina Otero, F.B. Gil, Marjorie Pizarro‐Guajardo, Daniel Paredes‐Sabja

This study shows that combining nystatin, taurocholate, and antibiotics, with nanoparticle delivery, reduces recurrent Clostridioides difficile infection by targeting intracellular spores.

bioRxiv · Oct 1, 2026 · PreprintPharmacology & Toxicology

CDDO-Imidazole regulates RBC alloimmunization to the KEL antigen by activating Nrf2

Che‐Yu Chang, Rosario Hernández‐Armengol, Kausik Paul, Juneyoung Lee, Karina Nance, Tomohiro Shibata, Peibin Yue, Christian Stehlik, David R. Gibb

This study shows that CDDO-Im, an Nrf2 activator, reduces RBC alloimmunization to the KEL antigen by suppressing IFNβ-stimulated gene expression and promoting RBC recovery in mice.

bioRxiv · Apr 3, 2025 · PreprintImmunology